Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

A cup of kidney beans covers 46.7% of the Daily Value (DV) for fiber, which is currently set at 28 grams (g ... Fiber and protein increase feelings of fullness by slowing down digestion and promoting ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...

This important study fills an gap in our knowledge of the evolution of GPCRs in holozoans, as well as the phylogeny of associated signaling pathway components such as G proteins, GRKs, and RIC8 ...

Because glucagon in animals has positive inotropic and chronotropic effects in the presence of beta-adrenergic blockade, catecholamine depletion or full digitalization, its cardiovascular effects i ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

Starbucks shared that their protein powder should be able to be added to any of its cold foam flavors. Starbucks “The good news is now I think we’re right on trend, and we can do it, I think ...

Experts are now turning their attention toward helping GLP-1 patients maintain muscle while dropping fat, according to a pair ...